Nemes Rush Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$135K Hold
5,100
0.01% 227
2025
Q1
$123K Buy
5,100
+100
+2% +$2.42K 0.02% 235
2024
Q4
$201K Hold
5,000
0.02% 188
2024
Q3
$410K Hold
5,000
0.06% 124
2024
Q2
$265K Hold
5,000
0.04% 140
2024
Q1
$410K Hold
5,000
0.06% 124
2023
Q4
$93.1K Buy
+5,000
New +$93.1K 0.02% 223